SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-037497
Filing Date
2022-11-14
Accepted
2022-11-14 07:35:56
Documents
63
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q stok-10q_20220930.htm   iXBRL 10-Q 2617257
2 EX-31.1 stok-ex311_9.htm EX-31.1 18398
3 EX-31.2 stok-ex312_8.htm EX-31.2 18295
4 EX-32.1 stok-ex321_10.htm EX-32.1 7205
5 EX-32.2 stok-ex322_7.htm EX-32.2 7878
6 GRAPHIC g2su0hd1o0aa000002.jpg GRAPHIC 27357
7 GRAPHIC g2su0hd1o0aa000003.jpg GRAPHIC 73735
8 GRAPHIC g2su0hd1o0aa000001.jpg GRAPHIC 41032
  Complete submission text file 0001564590-22-037497.txt   7630371

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA stok-20220930.xsd EX-101.SCH 45918
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE stok-20220930_cal.xml EX-101.CAL 42840
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE stok-20220930_def.xml EX-101.DEF 91740
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE stok-20220930_lab.xml EX-101.LAB 303079
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stok-20220930_pre.xml EX-101.PRE 215165
57 EXTRACTED XBRL INSTANCE DOCUMENT stok-10q_20220930_htm.xml XML 1183458
Mailing Address 45 WIGGINS AVENUE BEDFORD MA 01730
Business Address 45 WIGGINS AVENUE BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Filer) CIK: 0001623526 (see all company filings)

IRS No.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38938 | Film No.: 221380297
SIC: 2834 Pharmaceutical Preparations